-
2
-
-
0025273033
-
Cot mattress biodeterioration and SIDS
-
2 Richardson BA. Cot mattress biodeterioration and SIDS. Lancet 1990;335:670.
-
(1990)
Lancet
, vol.335
, pp. 670
-
-
Richardson, B.A.1
-
3
-
-
0028070814
-
Sudden infant death syndrome: A possible primary cause
-
3 Richardson BA. Sudden infant death syndrome: a possible primary cause. J Forensic Sci Soc 1994;34:199-204.
-
(1994)
J Forensic Sci Soc
, vol.34
, pp. 199-204
-
-
Richardson, B.A.1
-
4
-
-
0028585813
-
Fire retardants, biocides, plasticisers and sudden infant deaths
-
4 Fleming PJ, Cooke M, Chantler SM, Golding J. Fire retardants, biocides, plasticisers and sudden infant deaths. BMJ 1994;309:1594-5.
-
(1994)
BMJ
, vol.309
, pp. 1594-1595
-
-
Fleming, P.J.1
Cooke, M.2
Chantler, S.M.3
Golding, J.4
-
6
-
-
0028816029
-
Sudden infant death syndrome and volatile antimony compounds
-
6 Gates PN, Prindham JB, Webber JA. Sudden infant death syndrome and volatile antimony compounds. Lancet 1995; 345:386-7.
-
(1995)
Lancet
, vol.345
, pp. 386-387
-
-
Gates, P.N.1
Prindham, J.B.2
Webber, J.A.3
-
7
-
-
0028805016
-
Do microbiota cause emission of stibine from cot mattresses
-
7 Thompson M, Faull JL. Do microbiota cause emission of stibine from cot mattresses. Lancet 1995;346:1557-8.
-
(1995)
Lancet
, vol.346
, pp. 1557-1558
-
-
Thompson, M.1
Faull, J.L.2
-
8
-
-
0028827129
-
Toxic gas generation from plastic mattresses and sudden infant death syndrome
-
8 Warnock DW, Delves HT, Campbell CK, et al. Toxic gas generation from plastic mattresses and sudden infant death syndrome. Lancet 1995;346:1512-20.
-
(1995)
Lancet
, vol.346
, pp. 1512-1520
-
-
Warnock, D.W.1
Delves, H.T.2
Campbell, C.K.3
-
9
-
-
0030053282
-
Antimony, cot mattresses and SIDS
-
9 Taylor A. Antimony, cot mattresses and SIDS. Lancet 1996; 347:616.
-
(1996)
Lancet
, vol.347
, pp. 616
-
-
Taylor, A.1
-
10
-
-
0028922386
-
Cot mattresses and sudden infant death syndrome
-
10 Howatson AG, Patrick WJA, Fell GS, Lyon TBD, Gibson AAM. Cot mattresses and sudden infant death syndrome. Lancet 1995;345:1044-5.
-
(1995)
Lancet
, vol.345
, pp. 1044-1045
-
-
Howatson, A.G.1
Patrick, W.J.A.2
Fell, G.S.3
Lyon, T.B.D.4
Gibson, A.A.M.5
-
11
-
-
0030779171
-
Determination of antimony in urine, blood, serum and in liver and lung tissues of infants by ICP-MS
-
11 Delves HT, Sieniawska CS, Fell GS, et al. Determination of antimony in urine, blood, serum and in liver and lung tissues of infants by ICP-MS. Analyst 1997;122:1323-9.
-
(1997)
Analyst
, vol.122
, pp. 1323-1329
-
-
Delves, H.T.1
Sieniawska, C.S.2
Fell, G.S.3
-
13
-
-
0021001264
-
Metabolic behaviour of inorganic forms of antimony in the rat
-
Edinburgh: CEP Consultants Ltd
-
13 Edel J, Marafante E, Sabbioni E, Manzo L. Metabolic behaviour of inorganic forms of antimony in the rat. In: International conference on heavy metals in the environment, Heidelberg. Edinburgh: CEP Consultants Ltd, 1983:574-7.
-
(1983)
International Conference on Heavy Metals in the Environment, Heidelberg
, pp. 574-577
-
-
Edel, J.1
Marafante, E.2
Sabbioni, E.3
Manzo, L.4
-
14
-
-
0031966787
-
Antimony in blood and urine of infants
-
14 Cullen A, Kiberd B, Matthews T, Mayne P, Delves HT, O'Regan M. Antimony in blood and urine of infants. J Clin Pathol 1998;51:238-40.
-
(1998)
J Clin Pathol
, vol.51
, pp. 238-240
-
-
Cullen, A.1
Kiberd, B.2
Matthews, T.3
Mayne, P.4
Delves, H.T.5
O'Regan, M.6
-
15
-
-
0013868013
-
Analysis of diseased and normal lung tissue for trace antimony content by neutron activation analysis
-
15 Kennedy JH. Analysis of diseased and normal lung tissue for trace antimony content by neutron activation analysis. Am J Med Sci 1966;251:37-9.
-
(1966)
Am J Med Sci
, vol.251
, pp. 37-39
-
-
Kennedy, J.H.1
-
16
-
-
0014172068
-
Estimation of antimony in human enamel by activation analysis
-
16 Nixon GS, Livingston HD, Smith H. Estimation of antimony in human enamel by activation analysis. Caries Res 1967;1:327-32.
-
(1967)
Caries Res
, vol.1
, pp. 327-332
-
-
Nixon, G.S.1
Livingston, H.D.2
Smith, H.3
-
17
-
-
0015328280
-
Inhomogeneous but partly parallel distribution for cobalt, iron, selenium, zinc and antimony in different regions of liver, lung, kidney, heart and aorta, measured by neutron activation analysis
-
17 Schicha H, Kasperek K, Feinendegen LE, Siller V, Klein HJ. Inhomogeneous but partly parallel distribution for cobalt, iron, selenium, zinc and antimony in different regions of liver, lung, kidney, heart and aorta, measured by neutron activation analysis [in German]. Beitr Pathol 1972;146:55-62.
-
(1972)
Beitr Pathol
, vol.146
, pp. 55-62
-
-
Schicha, H.1
Kasperek, K.2
Feinendegen, L.E.3
Siller, V.4
Klein, H.J.5
-
19
-
-
0018841588
-
Distribution of trace elements in the human body determined by neutron activation analysis
-
19 Yukawa M, Amano K, Suzuki-Yasumoto M, Terai M. Distribution of trace elements in the human body determined by neutron activation analysis. Arch Environ Health 1980;35:36-44.
-
(1980)
Arch Environ Health
, vol.35
, pp. 36-44
-
-
Yukawa, M.1
Amano, K.2
Suzuki-Yasumoto, M.3
Terai, M.4
-
20
-
-
0003083143
-
Antimony
-
Friberg L, Norberg F, Vouk VB, eds. Amsterdam: Elsevier Science Publishers
-
20 Elinder CG, Friberg L. Antimony. In: Friberg L, Norberg F, Vouk VB, eds. The handbook on the toxicology of metals, 2nd ed. Amsterdam: Elsevier Science Publishers, 1986:26-42.
-
(1986)
The Handbook on the Toxicology of Metals, 2nd Ed.
, pp. 26-42
-
-
Elinder, C.G.1
Friberg, L.2
-
21
-
-
0023854488
-
Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate
-
21 Chulay JD, Fleckenstein L, Smith DH. Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate. Trans R Soc Trop Med Hyg 1988;82:69-72.
-
(1988)
Trans R Soc Trop Med Hyg
, vol.82
, pp. 69-72
-
-
Chulay, J.D.1
Fleckenstein, L.2
Smith, D.H.3
-
22
-
-
0028817521
-
Pharmacokinetics of antimony in patients treated with sodium stibogluconate for cutaneous leishmaniasis
-
22 Jaser MA, El-Yazigi A, Croft SL. Pharmacokinetics of antimony in patients treated with sodium stibogluconate for cutaneous leishmaniasis. Pharm Res 1995;12:113-16.
-
(1995)
Pharm Res
, vol.12
, pp. 113-116
-
-
Jaser, M.A.1
El-Yazigi, A.2
Croft, S.L.3
|